U.S. Markets close in 19 mins
  • S&P 500

    4,513.55
    -63.55 (-1.39%)
     
  • Dow 30

    34,418.77
    -221.02 (-0.64%)
     
  • Nasdaq

    14,991.89
    -389.43 (-2.53%)
     
  • Russell 2000

    2,154.38
    -51.96 (-2.35%)
     
  • Crude Oil

    66.06
    -0.44 (-0.66%)
     
  • Gold

    1,785.70
    +23.00 (+1.30%)
     
  • Silver

    22.55
    +0.23 (+1.05%)
     
  • EUR/USD

    1.1312
    +0.0006 (+0.0566%)
     
  • 10-Yr Bond

    1.3430
    -0.1050 (-7.25%)
     
  • Vix

    31.83
    +3.88 (+13.88%)
     
  • GBP/USD

    1.3233
    -0.0070 (-0.5227%)
     
  • USD/JPY

    112.7620
    -0.4470 (-0.3948%)
     
  • BTC-USD

    52,719.96
    -4,412.71 (-7.72%)
     
  • CMC Crypto 200

    1,336.53
    -105.23 (-7.30%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

Notable Halozyme Therapeutics Insider Trades $2.7M In Company Stock

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Helen Torley, President And CEO at Halozyme Therapeutics (NASDAQ:HALO), made a large buy and sell of company shares on October 4, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Helen Torley exercised options to purchase 50,000 Halozyme Therapeutics shares at a price of $14.66 per share for a total of $733,000 on October 4. They then sold their shares on the same day in the open market. They sold at prices ranging from $39.97 to $40.95 to raise a total of $2,004,390 from the stock sale.

Following the transaction, Torley still owns 537,160 shares of the company, worth $21,577,717.

Halozyme Therapeutics shares are trading up 0.43% at $40.17 at the time of this writing on Tuesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Halozyme Therapeutics's Insider Trades.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.